WATapp
Research type
Research Study
Full title
An assessment of the Wolverhampton Assessment Tool, an application to allow self-monitoring of wellbeing in patients with prostate cancer, to gauge whether patient perception correlates with clinical status
IRAS ID
284454
Contact name
David Matheson
Contact email
Sponsor organisation
University of Wolverhampton
Clinicaltrials.gov Identifier
Duration of Study in the UK
0 years, 11 months, 30 days
Research summary
This is a study of the Wolverhampton Assessment Tool (WATapp), a five-item questionnaire for patients with advanced or metastatic prostate cancer to say how they feel normally in terms of pain, urinary frequency, eating, and tiredness. It is widely recognised that patient-reported outcomes give a measure of overall effect of clinicians’ actions on patients and that they can be used to guide the management of the patient’s condition.
WATapp is designed to reduce the need for the patient to attend hospital so much for routine follow-up consultations (an important aspect in light of COVID-19), to give the man some sense of agency and control and to inform his clinician of just he feels he is coping with his treatment. Now we want to find out just how the results from WATapp correspond to, for example, changes in PSA, testosterone or other blood results which are routinely measured; and to find out how patients and clinicians feel about using WATapp.
Men with advanced or metastatic prostate cancer will be eligible to take part in the study and participation is in addition to whatever treatment they are on. Clinicians who choose to offer WATapp to their patients will also be invited to take part and they will be asked to share with the researchers anonymised, linked patient data and scores from WATapp.
The study will take place in NHS oncology departments, beginning in Wolverhampton, and will last three years. An eventual aim is to make the WATapp available, free of charge, as an app on both the Android Store and the Apple App Store. This will allow patients to self-monitor aspects of their health and to share this as they wish with their clinician. Users will be asked to evaluate the app by the usual means on their app store.
REC name
West Midlands - Black Country Research Ethics Committee
REC reference
20/WM/0183
Date of REC Opinion
4 Aug 2020
REC opinion
Further Information Favourable Opinion